Milestone Pharmaceuticals’ CARDAMYST: A Promising Buy with FDA Decision and Phase 3 Trial on Horizon
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
Indiatimes43m
Kama Holdings Share Price
Kama Holdings Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 8,134.64 Crore) operating in Holding Company sector. Kama Holdings Ltd. key Products/Revenue Segments ...